U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508839) titled 'Evaluation of the Safety and Efficacy of SALI-10 Probiotic Lozenges' on Dec. 16, 2025.
Brief Summary: Gingivitis is among the most common oral conditions, affecting 50-90% of adults globally. It is a reversible inflammatory disease triggered primarily by the accumulation of microbial plaque on teeth and gingival tissues. Standard treatment involves plaque reduction and maintenance of oral hygiene, often supplemented with antimicrobial therapeutics to prevent disease progression. While plaque control remains the cornerstone of prevention, emerging research points to certain beneficial microbes that may protect gingival health. Notabl...